CSPC Pharmaceutical Group Limited: all 344 studies

Page 2 of 4. Open to participants first (160), then studies with results posted, then the rest; newest registration first within each.

• First-in-Human Investigation of JMT108 Injection in Participants With Advanced Malignant TumorsRecruitingNCT06877650Phase 1/2
• A Study of JMT203 in Patients With Cancer CachexiaRecruitingNCT06868849Phase 1/2
• JSKN003 Versus Trastuzumab Emtansine (T-DM1) for HER2-Positive, Advanced Breast CancerRecruitingNCT06846437Phase 3
• Study of SYH2062 Injection in Healthy Chinese VolunteersRecruitingNCT06842537Phase 1
• The Safety, Tolerability, and Pharmacokinetics of of SYH9017 in Chinese Participants With Overweight and ObesityRecruitingNCT06830343Phase 1
• A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-TKIsRecruitingNCT06829459Phase 3
• The Research of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With DepressionNot yet recruitingNCT06827431Phase 3
• Clinical Trial of SYS6010±SYH2051 Versus Chemotherapy in Advanced Breast Cancer and Other Solid TumorsNot yet recruitingNCT06775236Phase 1/2
• A Phase III Clinical Trial Evaluating the Efficacy and Safety of Valsartan/Levamlodipine (SYH9056) Tablets In Hypertensive PatientsNot yet recruitingNCT06771245Phase 3
• A Clinical Study of JMT101 in Combination With Osimertinib Versus Osimertinib Alone as First-Line Treatment for Patients With Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Sensitive MutationsRecruitingNCT06735391Phase 3
• A Study of JMT601 in Participants With Relapsed or Refractory CD20-positive B-cell Non-Hodgkin LymphomaRecruitingNCT06725524Phase 1
• A Study of SYS6020 Injection in Refractory Active Systemic Lupus ErythematosusNot yet recruitingNCT06694298Phase 1
• A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR T-cells in Patients With Refractory Generalized Myasthenia GravisRecruitingNCT06688435Phase 1
• A Clinical Study of Paclitaxel Cationic Liposomes for the Treatment of Patients With Advanced Solid TumorsRecruitingNCT06632574Phase 1
• Liposomal Irinotecan in Combination With Oxaliplatin and S-1 Versus Gemcitabine Combined With Capecitabine as Postoperative Adjuvant Therapy for Pancreatic CancerNot yet recruitingNCT06571461Phase 3
• A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of JMT202Enrolling by invitationNCT06564467Phase 1
• Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata PatientsNot yet recruitingNCT06562894Phase 2
• A Study of CM310 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNot yet recruitingNCT06547333Phase 2/3
• Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and VomitingNot yet recruitingNCT06543966Phase 3
• A Study to Evaluate the Efficacy and Safety of the Combination of Glumetinib and Docetaxel（Albumin Bound）Verse Docetaxel for the Treatment of MET-overexpressed Non-small Cell Lung CancerNot yet recruitingNCT06525350Phase 2
• A Study to Evaluate the Efficacy and Safety of SYHX1901 Tablet in Non-segmental Vitiligo PatientsRecruitingNCT06511739Phase 2
• A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)RecruitingNCT06505395Phase 2
• A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic CancerNot yet recruitingNCT06492941Phase 3
• Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With PresbyopiaNot yet recruitingNCT06451666Phase 3
• A Study to Evaluate the Efficacy of ALMB-0168 in Solid Tumor Patients With Bone Metastatic Whose Prior Standard Treatment Have FailedNot yet recruitingNCT06416358Phase 2
• A Study to Evaluate Pregabalin in Painful Diabetic Peripheral NeuropathyNot yet recruitingNCT06383702Phase 3
• JMT101 in Combination With Osimertinib, Versus Cisplatin-pemetrexed in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Exon 20ins MutationsNot yet recruitingNCT06380348Phase 3
• A Study to Evaluate the Efficacy and Safety in Subjects With Advanced Breast Cancer Treated With SYHX2011Not yet recruitingNCT06354114Phase 2
• Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung CancerNot yet recruitingNCT06319313Phase 2/3
• DP303c Versus Trastuzumab Emtansine in in Patients With HER2-positive Advanced Breast CancerRecruitingNCT06313086Phase 3
• A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerRecruitingNCT06296706Phase 3
• A Study of NBL-028 in Patients With Advanced Solid TumorsRecruitingNCT06223256Phase 1
• A Study to Assess the Prevention of Bone-related Events in Patients With Bone Metastases From Malignant Solid Tumors Treated With JMT103 Compared to Zoledronic AcidNot yet recruitingNCT06221072Phase 3
• A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid LeukemiaNot yet recruitingNCT06182592Phase 3
• A Study of Docetaxel for Injection (Albumin-bound) and SG001 in Combination With Cisplatin and Simultaneous Radiotherapy for Locally Advanced Unresectable Esophageal Squamous Carcinoma.Not yet recruitingNCT06136988Phase 1/2
• A Study of JMT101 in Patients With Metastatic Colorectal CancerNot yet recruitingNCT06089330Phase 2
• A Study of SYH2051 Monotherapy in Advanced Solid Tumors or in Combination With Radiotherapy in Locally Advanced Head and Neck CancerRecruitingNCT06011291Phase 1
• DP303c in Patients With HER2-positive Advanced Breast CancerNot yet recruitingNCT05901935Phase 3
• A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.RecruitingNCT05877924Phase 1
• Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)RecruitingNCT05875428Phase 2
• A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)RecruitingNCT05863325Phase 2
• Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.RecruitingNCT05838066Phase 3
• A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of BoneNot yet recruitingNCT05813665Phase 3
• A Bioequivalence Study of (Cytarabine: Daunorubicin) Liposome for InjectionRecruitingNCT05801835Not applicable
• A Study of Clevidipine Butyrate Injectable Emulsion in the Treatment of Hypertensive Emergency and Sub-emergencyNot yet recruitingNCT05783557Phase 3
• A Study of CM310 in Subjects With Moderate to Severe AsthmaRecruitingNCT05761028Phase 2/3
• Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant TumorsNot yet recruitingNCT05728541Phase 1
• Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast CancerRecruitingNCT05720026Phase 3
• Clinical Study of Mitoxantrone Hydrochloride Liposome Injection Combined With Capecitabine Versus Capecitabine Monotherapy in Patients With Recurrent Metastatic Nasopharyngeal Carcinoma Who Failed Platinum-containing TreatmentNot yet recruitingNCT05717764Phase 3
• Efficacy and Safety Study of First-line Treatment With SG001 Plus Chemotherapy ± Bevacizumab Versus Placebo Plus Chemotherapy ±Bevacizumab for Recurrent, or Metastatic Cervical Cancer With PD-L1 Positive (CPS≥1)Not yet recruitingNCT05715840Phase 3
• A Study of Docetaxel for Injection (Albumin-bound) in Patients With Pancreatic CancerRecruitingNCT05616494Phase 2
• A Study Evaluating SYHX2005 in the Treatment of Patients With Advanced Solid TumorsNot yet recruitingNCT05609019Phase 1
• A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid TumorsNot yet recruitingNCT05508659Phase 1/2
• A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Efficacy of Cisplatin Micelle Injection (HA132) in Patients With Advanced Malignant Solid TumorsNot yet recruitingNCT05478785Phase 1/2
• SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT05445154Phase 1/2
• KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line TherapyRecruitingNCT05427383Phase 2/3
• To Evaluate the Safety and Tolerability of SYHX2001 in Patients With Advanced or Metastatic Solid TumorsRecruitingNCT05407909Phase 1
• Evaluation of the Safety and Efficacy of NBL-015 in Patients With Advanced Solid TumorsNot yet recruitingNCT05153096Phase 1
• A Study to Evaluate the Safety and Tolerance of SYHX1903 in Patients With Relapsed/Refractory Hematologic MalignanciesNot yet recruitingNCT05055791Phase 1/2
• A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-MutatedRecruitingNCT04716114Phase 3
• A Clinical Trial to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Octreotide Long-acting Injection in Patients With AcromegalyCompletedNCT07814651Phase 2
• A Study of SYH2082 Injection in Healthy ParticipantsActive, not recruitingNCT07736404Phase 1
• A Study of SYH2069 Injection in Healthy ParticipantsActive, not recruitingNCT07736391Phase 1
• Food-effect Study of Ammoxetine Hydrochloride Enteric-coated TabletsCompletedNCT07508501Phase 1
• A Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetics of Ammoxetine Hydrochloride Enteric-coated Tablets in Healthy SubjectsCompletedNCT07508462Phase 1
• A Study to Evaluate the Safety, Efficacy of SYH2053 in Chinese Participants With Non-familial Hypercholesterolemia and Mixed HyperlipidemiaCompletedNCT07421232Phase 2
• Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With SchizophreniaCompletedNCT07268430Not applicable
• A Study to Evaluate the Safety, Efficacy, and PPK of ABCD in Patients With IMDCompletedNCT07239765Phase 3
• Clinical Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SYS6045 in Patients With HER2-Positive, Expressing, or Mutated Advanced Malignant Solid TumorsActive, not recruitingNCT07122063Phase 1/2
• A Study of Prusogliptin Tablets Combined With Dapagliflozin Tablets and Metformin Hydrochloride Extended Release Tablets in Type 2 DiabetesActive, not recruitingNCT07026968Phase 3
• Sirolimus for Injection (Albumin-bound) in Combination With Endocrine Therapy for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Who Have Failed Standard TherapyActive, not recruitingNCT06957379Phase 2
• A Phase III Study of KN026 in Combination With HB1801 ± Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast CancerActive, not recruitingNCT06747338Phase 3
• Semaglutide in Treatment of ObesityCompletedNCT06604624Phase 3
• JMT101 Combined With Osimertinib in Patients With Stage Ⅲb-Ⅳ Non-small Cell Lung Cancer (NSCLC) Characterized by Epithermal Growth Factor Receptor (EGFR) Common MutationsActive, not recruitingNCT06391944Phase 2
• Efficacy and Safety Study of Meloxicam Nanocrystal Injection for the Treatment of Moderate to Severe PainCompletedNCT06379165Phase 3
• Bioequivalence Study of Olaparib Tablets Under Fasting and Fed Conditions in Healthy SubjectsCompletedNCT06360445Phase 1
• A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes MellitusCompletedNCT06258148Phase 3
• A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes MellitusCompletedNCT06235086Phase 3
• A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053CompletedNCT06229548Phase 1
• A Study of TG103 Injection in the Management of Non-diabetic Overweight or ObesityCompletedNCT06226090Phase 2
• Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes MellitusCompletedNCT06161844Phase 3
• A Study of TG103 Injection in Non-diabetic Overweight or ObesityCompletedNCT05997576Phase 3
• Bioequivalence of Amphotericin B Liposome for InjectionCompletedNCT05913921Phase 1
• An Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque PsoriasisCompletedNCT05858047Phase 2
• A Study of DP303c in Patients With HER2-positive Advanced Solid TumorsStatus unknownNCT05810103Phase 1
• A Study of CM326 in Subjects With Moderate to Severe AsthmaStatus unknownNCT05774340Phase 2
• The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With DepressionStatus unknownNCT05762458Phase 2
• A Single-dose Study of Octreotide Injection in Healthy Adult SubjectsCompletedNCT05761431Phase 1
• A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)Status unknownNCT05753865Phase 3
• A Study of ABCD for Injection in Subjects With Invasive Candidiasis and Invasive AspergillusCompletedNCT05707832Phase 3
• A Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric CancerStatus unknownNCT05705635Phase 2
• A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)Status unknownNCT05625919Phase 1/2
• Efficacy and Safety of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD)CompletedNCT05551598Phase 2
• Study to Evaluate the Safety and Pharmacokinetics of ALMB-0166 in Patients With Acute Spinal Cord InjuryCompletedNCT05524103Phase 1
• Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung CancerStatus unknownNCT05513664
• A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid TumorsStatus unknownNCT05508620Phase 1
• A Study of Mitoxantrone Hydrochloride Liposome Injection for Relapsing Multiple SclerosisWithdrawnNCT05496894Phase 2
• A Study to Explore the Efficacy of Alprostadil Liposomes Injection in the Prevention of CI-AKITerminatedNCT05475717Phase 2
• A Study of SARS-CoV-2 mRNA Vaccine (SYS6006) in Chinese Healthy Participants Aged 18 Years or MoreActive, not recruitingNCT05439824Phase 2
• A Real-world Study on Patients of Unresectable Giant Cell Tumor of BoneCompletedNCT05402865

← CSPC Pharmaceutical Group Limited overview and focus areas